CLINICAL_TRIALS
trial_result
· 2024-10-15
Clinical Trial Update: Persistence of Protection by Shingrix [Phase 4]
Summary
Phase 4 trial updates show persistence of protection from Shingrix against herpes zoster; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Herpes Zoster | Phase 4 | Status: COMPLETED | Results posted: 2024-10-15